BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Lone Star Bio

  Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate TissueEnd of Study Top-line Data Available Late-2022

  Nanospectra Biosciences, Inc. today announced the completion of enrollment of its open-label, multi-center, single-treatment pivotal study of AuroLase Therapy for focal ablation of prostate tissue via nanoparticle directed near infrared irradiation.

  November 2, 2021

   · 

  4 min read
• Drug Development

  Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial

  Clene Inc. today announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).

  November 2, 2021

   · 

  11 min read
• Genetown

  Cogent Biosciences to Present Virtually at Jefferies London Healthcare Conference 2021

  Cogent Biosciences, Inc. today announced that Andrew Robbins, Chief Executive Officer and President, will participate in a fireside chat and one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021.

  November 2, 2021

   · 

  1 min read
• Business

  Bausch Health Companies Inc. Announces Third-Quarter 2021 Results

  Bausch Health Companies Inc. announced its third-quarter 2021 financial results.

  November 2, 2021

   · 

  54 min read
• Biotech Bay

  Antiva Biosciences Closes $31 Million Series D Equity Financing

  Antiva Biosciences today announced the closing of a $31 million Series D equity financing.

  November 2, 2021

   · 

  5 min read
• FDA

  FDA Clears 12 New XO Cross Microcatheters

  Transit Scientific announced the FDA clearance of new hydrophilic-coated XO Cross Microcatheters for guidewire support, exchange, and contrast media injection in the peripheral vasculature.

  November 2, 2021

   · 

  3 min read
• Business

  Jnana Therapeutics Announces Promotion of Joel Barrish, Ph.D., to President and Chief Scientific Officer

  Jnana Therapeutics today announced the promotion of Joel Barrish, Ph.D., a co-founder of the company, to President and Chief Scientific Officer from his previous role as Chief Scientific Officer.

  November 2, 2021

   · 

  3 min read
• Cybin Hosting Research and Development Briefing on November 8, 2021

  Cybin Inc. will host an in-person and virtual research and development (“R&D”) briefing releasing positive research findings and data on Monday, November 8, 2021 from 8:30 am to 9:30 am (EST)

  November 2, 2021

   · 

  6 min read
• Business

  Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

  Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

  November 2, 2021

   · 

  6 min read
• Business

  Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

  Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDT

  November 2, 2021

   · 

  11 min read